McLaren Greater Lansing — Lansing, Michigan

Public research footprint of McLaren Greater Lansing, compiled from the ClinicalTrials.gov public registry.

102

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Locally Advanced Unresectable Digestive System Neuroendocrine Neoplasm · Stage II Bladder Urothelial Carcinoma AJCC v6 and v7 · Stage IIA Breast Cancer AJCC v6 and v7 · Hormone Receptor-Positive Breast Carcinoma

Recently updated registry entries

NCT07343297 — Ask Questions About Clinical Trials (Recruiting)
NCT06055920 — The PEERLESS II Study (Active Not Recruiting)
NCT03419234 — Abiraterone Acetate and Antiandrogen Therapy With or Without Cabazitaxel and Prednisone… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at McLaren Greater Lansing?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 07, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.